There's never a dull week on Wall Street. Let's go over some of the news that will shape the week to come.
The trading week begins with Vertex Pharmaceuticals (NAS: VRTX) reporting its latest quarterly results on Monday. Analysts see the once-profitless biotech posting its fourth consecutive substantial profit in a row.
Frontier Communications (NYS: FTR) is one of the many companies reporting on Tuesday. The broadband, digital phone, and TV service provider is expected to post a quarterly profit of $0.05 a share. The one troubling trend Frontier needs to overcome is that it's missed Wall Street's profit targets in three of the past four quarters.
If the market finds itself lost in the middle of the week, it's always nice to have Garmin (NAS: GRMN) around. The GPS giant reports on Wednesday. In a somewhat surprising development, the market's banking on a bottom-line improvement for the quarter.
LinkedIn (NAS: LNKD) has a very important job interview to tackle on Thursday. The corporate social-networking specialist is reporting its latest financials exactly one week after Facebook posted disappointing quarterly results.
Don't blow it, LinkedIn. The job of market leadership in social networking can be yours if you play your cards right.
The final trading day of the week is usually quiet, but we're still ribcage-deep in earnings season. A big name to watch on Friday is Procter & Gamble (NYS: PG) . The company behind Crest toothpaste, Tide laundry detergent, and Pampers diapers is expected to post net income of $0.77 a share, short of the $0.84 it served up a year earlier.
Procter & Gamble also makes Bounty paper towels. Does that make its investors Bounty hunters?
May the jokes get better for you over the weekend.
Check that calendar
If you like to stay on top of what happens next -- and I'm guessing you do, because you're reading this article -- how about checking out The Motley Fool's top stock for 2012? It's a free report, but only for a limited time, so check it out now.
The article The Fool Looks Ahead originally appeared on Fool.com.
The Motley Fool owns shares of LinkedIn.Motley Fool newsletter serviceshave recommended buying shares of LinkedIn, Procter & Gamble, and Vertex Pharmaceuticals. We Fools don't all hold the same opinions, but we all believe thatconsidering a diverse range of insightsmakes us better investors. Try any of our Foolish newsletter servicesfree for 30 days.Longtime Fool contributorRick Munarrizcalls them as he sees them. He owns no shares in any of the stocks in this story andis also part of theRule Breakersnewsletter research team, seeking out tomorrow's ultimate growth stocks a day early. The Motley Fool has adisclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.